0001209191-17-067417.txt : 20171227
0001209191-17-067417.hdr.sgml : 20171227
20171227164809
ACCESSION NUMBER: 0001209191-17-067417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171227
FILED AS OF DATE: 20171227
DATE AS OF CHANGE: 20171227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandercock Colin
CENTRAL INDEX KEY: 0001724870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 171276484
MAIL ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-27
0
0001645460
Cue Biopharma, Inc.
CUE
0001724870
Sandercock Colin
675 W. KENDALL STREET
CAMBRIDGE
MA
02142
0
1
0
0
SVP, General Counsel and Sec
Stock Options
7.50
2017-12-27
4
A
0
150000
0.00
A
2024-12-27
Common Stock
150000
150000
D
These Stock Options become exercisable in eight equal semi-annual installments beginning June 5, 2018.
/s/ Colin Sandercock by Mark Busch, as attorney-in-fact
2017-12-27